PE-0503

N/A

Report date: 2025/06/11 11:06:26

Base Information

Drug NamePE-0503
Drug Alias NameGlucagon-like peptide-2 (PhaseBio)GLP-2-ELPPE-0503
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionGlucagon-like peptide 2 receptor agonists
TargetsGlucagon-like peptide 2 receptor
Therapy Area/IndicationsShort Bowel SyndromeMucositisCrohn Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPhasebio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPhasebio Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsShort Bowel SyndromeMucositisCrohn Disease
Inactive IndicationsGastrointestinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A